Table 1. Expression of SEMA3, Plexin and NRP in patients with PDAC.
Molecule | Case | Immuno-positivity (number, %) | |
No. | Tumor | Ductal epithelia | |
SEMA3A | 59 | 32 (54.24%),** | 0 (0%) |
SEMA3B | 60 | 41 (68.33%),** | 0 (0%) |
SEMA3C | 62 | 24 (38.71%),** | 0 (0%) |
SEMA3E | 62 | 58 (93.55%),** | 0 (0%) |
SEMA3F | 59 | 28 (47.46%),** | 0 (0%) |
PLXNA1 | 60 | 19 (31.67%),** | 0 (0%) |
PLXNA2 | 61 | 42 (68.85%),** | 0 (0%) |
PLXNA3 | 57 | 38 (66.67%),** | 0 (0%) |
PLXND1 | 62 | 57 (91.94%),** | 0 (0%) |
NRP1 | 62 | 57 (91.94%),** | 0 (0%) |
NRP2 | 62 | 9 (14.52%),** | 0 (0%) |
Paired t-test,
: P<0.0001.